Clinical Trials on Myasthenia Gravis, Juvenile Form in Brazil
Total 6 results
-
Alexion PharmaceuticalsCompletedRefractory Generalized Myasthenia GravisItaly, United Kingdom, Spain, Belgium, Turkey, Japan, United States, Netherlands, Korea, Republic of, Argentina, Hungary, Sweden, Denmark, Brazil, Czechia, Finland, Canada
-
Hoffmann-La RocheChugai PharmaceuticalRecruitingGeneralized Myasthenia GravisFrance, Korea, Republic of, China, Argentina, Spain, Brazil, Russian Federation, Japan, Denmark, Australia, Italy, Turkey, Germany, United States, Netherlands, Taiwan, Poland, Canada
-
Alexion PharmaceuticalsCompletedRefractory Generalized Myasthenia GravisKorea, Republic of, United States, Spain, Canada, Netherlands, Belgium, Czechia, Denmark, Italy, Australia, Finland, Turkey, Germany, Greece, Brazil, Argentina, Japan, United Kingdom, Hungary, France, Sweden
-
Alexion Pharmaceuticals, Inc.RecruitingGeneralized Myasthenia GravisChina, United States, Spain, United Kingdom, Korea, Republic of, Italy, Germany, Japan, Brazil, France, Netherlands, Taiwan, Turkey, Israel, Poland, Austria, Denmark, Portugal, Canada, Serbia, Argentina, Switzerland
-
AmgenActive, not recruitingMyasthenia GravisUnited States, Argentina, Belarus, Brazil, Canada, China, Denmark, France, Germany, India, Italy, Japan, Korea, Republic of, Poland, Russian Federation, Spain, Taiwan, Turkey, Ukraine
-
University of Alabama at BirminghamNational Institute of Neurological Disorders and Stroke (NINDS)CompletedMyasthenia GravisThailand, Canada, Germany, Italy, Netherlands, Brazil, United States, Argentina, Australia, Chile, Japan, Mexico, Poland, Portugal, South Africa, Spain, Taiwan, United Kingdom